Trial Profile
Safety and efficacy of ritonavir-boosted atazavavir (ATV/r) compared with ritonavir-boosted darunavir (DRV/r) or raltegravir in HIV-1 infected patients: The Italian Cohort Naives Antinetrovirals (ICONA) foundation study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jan 2020
Price :
$35
*
At a glance
- Drugs Atazanavir/ritonavir (Primary) ; Darunavir/ritonavir (Primary) ; Raltegravir (Primary) ; Abacavir; Emtricitabine; Lamivudine; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 12 Mar 2018 New trial record
- 01 Mar 2018 Results published in the HIV Clinical Trials